SCALE-C: Strategies for hepatitis C testing and treatment in Aboriginal communities that Lead to Elimination [ 2018 - 2022 ]

Research Grant

[Cite as]

Researchers: A/Pr James Ward (Principal investigator) ,  A/Pr Gail Matthews A/Pr Jason Grebely A/Pr Kathy Petoumenos Dr Tanya Applegate
View all 7 related researchers

Brief description Prevalence of hepatitis C infection within the Aboriginal population is among the highest of any identifiable population in Australia. Highly effective, direct-acting antiviral (DAA) therapy, and their listing on the PBS in 2016 has revolutionised HCV clinical management in Australia. The SCALE-C study will evaluate an established test and treat model to rapidly scale-up DAA within four Aboriginal communities to determine both impact on community prevalence and ongoing transmission.

Funding Amount $AUD 2,175,170.35

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]